StockWatch
·
Specialty Chemicals
Shareholding9 Sept 2026, 08:00 pm

Sudarshan Pharma: Revised Promoter Share Pledge Disclosures Filed

AI Summary

Sudarshan Pharma Industries Ltd has filed revised disclosures under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, concerning the creation of pledge on equity shares. The disclosures pertain to shares held by Mrs. Devangi Hemal Mehta, Mrs. Namrata Sachin Mehta, M/s. Hemal V Mehta HUF, and M/s. Sachin V Mehta HUF, all classified under the 'Promoter Group' category. These revised filings follow an earlier email dated September 4th, 2026, and are in accordance with Regulation 31(2) of the SEBI Takeover Regulations. The company has requested the BSE to take these revised disclosures on record.

Key Highlights

  • Revised SEBI Takeover Regulations disclosures filed by Sudarshan Pharma.
  • Pledge creation on equity shares by promoter group entities.
  • Filings are in accordance with Regulation 31(1) and 31(2) of SEBI.
  • BSE has been requested to record the revised disclosures.